Advertisement
The potential risk for reinfection with COVID-19 remains a concern

Risk for COVID-19 Reinfection Remains Unknown

0
Jeffrey Shaman, Ph.D., of Climate and Health Program at Columbia University, spoke with HD Live! about COVID-19 reinfection risk
Antibiotic prescription rates are high in low- and middle-income countries

Antibiotic Prescribing High in Low-, Middle-Income Countries

0
Proportion of patients with inappropriate prescriptions ranged from 8 to 100 percent
The cheap and widely available steroid dexamethasone reduced the risk for death among seriously ill COVID-19 patients by up to a third

Steroid May Reduce COVID-19 Death Risk by Up to One-Third

0
Dexamethasone appears promising for patients with severe illness
The rate of COVID-19 cases is increased on American Indian reservations with larger proportions of homes lacking complete indoor plumbing

Correlates of COVID-19 ID’d on American Indian Reservations

0
Rate of cases higher on American Indian reservations with larger proportion of homes lacking plumbing
For patients with relapsing multiple sclerosis

Therapeutic Hookworm Explored for Relapsing Multiple Sclerosis

0
No effect seen for hookworm versus placebo on number of new/enlarging/enhancing lesions
Greater health system use and higher costs are seen with nine months of isoniazid compared with four months of rifampin in both adults and children treated for latent tuberculosis infection

Four Months of Rifampin Costs Less Than Nine Months Isoniazid

0
Health system use and costs higher for nine months of isoniazid in adults and children in all settings
Patient-collected lower nasal specimens may be acceptable for severe acute respiratory syndrome coronavirus 2 testing

Self-Collected Nasal Swabs Acceptable for SARS-CoV-2 Testing

0
Diagnostic equivalence seen across patient-collected nasal swabs, doctor-collected nasal, oropharyngeal swabs
Mandated face coverings represent the most effective means to prevent interhuman transmission of COVID-19

Face Masks Most Effective Means to Avert COVID-19 Transmission

0
Airborne transmission is dominant route for spread; masks are determinant for shaping pandemic trend
In the treatment of COVID-19 patients

Hydroxychloroquine-Remdesivir Combo Dangerous for COVID-19 Patients

0
FDA says chloroquine or hydroxychloroquine could reduce the antiviral effectiveness of remdesivir
The cumulative incidence of COVID-19 is 403.6 cases per 100

CDC: Cumulative Incidence of COVID-19 403.6 Per 100,000 in U.S.

0
Hospitalization and mortality six times, 12 times higher for patients reporting an underlying condition